This video examines how to manage the side effects of estrogen deprivation in breast cancer patients, including vaginal dryness and hot flashes.
Treatment with aromatase inhibitors can cause a host of early side effects in breast cancer patients, including vaginal dryness and hot flashes.
In this video Ann Partridge, MD, MPH, of the Dana-Farber Cancer Institute in Boston, discusses management strategies for these early side effects of estrogen deprivation.
Giredestrant Combo Yields Positive PFS in Subgroups After CDK4/6i in ER+/HER2– Breast Cancer
December 13th 2025“The magnitude of clinical benefit was clinically meaningful and consistent, and was regardless of PIK3CA mutations or alterations in the PIK3CA pathway, duration of prior CDK4/6 inhibitors, including patients who progress within 6 to 12 months, and the choice of prior CDK4/6 inhibitors,” said Hope S. Rugo, MD.